News-Medical.Net on MSN
AI tool predicts metastatic risk in multiple cancers
Why do some tumors spread while others remain localized? The mechanisms governing the metastatic potential of tumor cells ...
Bria-IMT demonstrates a median overall survival of 15.6 months, surpassing historical data for heavily pretreated metastatic ...
The FDA has granted 510(k) clearance to Brain Mets, an AI-based software platform designed to aid in the detection, tracking and treatment planning of brain metastases. The tool, developed by Neosoma, ...
A retrospective analysis finds that patients with lung-only metastatic pancreatic cancer have better overall survival, are ...
9don MSN
A mechanical view on metastasis: Tumor cell viscosity found to guide key steps in cancer spread
Millions of people worldwide are diagnosed with cancer every year. In advanced tumor diseases, cancer cells detach from the ...
Outcome with pertuzumab, docetaxel, and trastuzumab (PTH) regimen in patients with HER2 positive metastatic breast cancer: Real-world data from a single center in India. This is an ASCO Meeting ...
Chemotherapy commonly damages the intestinal lining, a well-known side effect. But this injury does not remain confined to the gut. It reshapes nutrient availability for intestinal bacteria, forcing ...
In this analysis, researchers aimed to evaluate the clinicopathologic characteristics, metastatic patterns, and survival outcomes in patients with metastatic prostate cancer and low-volume primary ...
Data identify nuclear PD-L1 as a previously unaddressed driver of immunotherapy resistance and metastatic progression SYDNEY, Jan. 30, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA), an ...
Deep learning analysis of FDG PET-CT improves survival prediction in non-metastatic breast cancer, outperforming standard staging and single modality models while supporting interpretable and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results